Antimicrobial dosages for adults with impaired kidney function: I
This table gives dosing recommendations for adults with impaired kidney function. For antimicrobial dosing in children with impaired kidney function, seek expert advice.
|
imipenem+cilastatin | |
|
dose expressed as imipenem component 500 to 1000 mg loading dose may be required | |
|
Dosage adjustment based on GFR [NB2] | |
|
more than 60 mL/min |
normal |
|
30 to 60 mL/min |
500 mg 6- to 8-hourly |
|
20 to 29 mL/min |
250 mg 8-hourly to 500 mg 12-hourly |
|
less than 20 mL/min |
avoid; if essential, 250 to 500 mg 12-hourly (usually 500 mg 12-hourly) |
|
Dosages for dialysis | |
|
intermittent haemodialysis |
as for GFR less than 20 mL/min |
|
peritoneal dialysis |
no data |
|
continuous renal replacement therapy |
500 mg 6 to 8-hourlyBoucher 2016Cotton 2005 |
|
indinavir | |
|
Dosage adjustment based on GFR [NB2] | |
|
more than 50 mL/min |
normal |
|
10 to 50 mL/min |
normal |
|
less than 10 mL/min |
normal |
|
Dosages for dialysis [NB2] | |
|
intermittent haemodialysis |
normal |
|
peritoneal dialysis |
normal |
|
continuous renal replacement therapy |
normal |
|
isavuconazole | |
|
Dosage adjustment based on GFR [NB2] | |
|
more than 50 mL/min |
normal |
|
10 to 50 mL/min |
normal |
|
less than 10 mL/min |
normal |
|
Dosages for dialysis [NB2] | |
|
intermittent haemodialysis |
normal |
|
peritoneal dialysis |
normal |
|
continuous renal replacement therapy |
normal |
|
isoniazid | |
|
Dosage adjustment based on GFR [NB2] | |
|
more than 50 mL/min |
normal |
|
10 to 50 mL/min |
normal |
|
less than 10 mL/min |
normal |
|
Dosages for dialysis [NB2] | |
|
intermittent haemodialysis |
normal; dose after dialysis |
|
peritoneal dialysis |
normal |
|
continuous renal replacement therapy |
normal |
|
itraconazole | |
|
Dosage adjustment based on GFR [NB2] | |
|
more than 50 mL/min |
normal |
|
10 to 50 mL/min |
normal |
|
less than 10 mL/min |
normal |
|
Dosages for dialysis [NB2] | |
|
intermittent haemodialysis |
normal |
|
peritoneal dialysis |
normal |
|
continuous renal replacement therapy |
normal |
|
ivermectin | |
|
Dosage adjustment based on GFR [NB2] | |
|
more than 50 mL/min |
normal |
|
10 to 50 mL/min |
normal |
|
less than 10 mL/min |
normal |
|
Dosages for dialysis [NB2] | |
|
intermittent haemodialysis |
normal |
|
peritoneal dialysis |
normal |
|
continuous renal replacement therapy |
normal |
|
Note:
GFR = glomerular filtration rate NB1: Dosing in patients with kidney impairment is complex. This table is intended as a guide only, see General considerations for antimicrobial dosage modification in kidney impairment. If relevant, see Dialysis and continuous renal replacement therapy for further guidance on using this table. NB2: ‘Normal’ indicates that the standard dosage regimen for the specific indication in these guidelines should be used. NB3: For multiple-daily doses, percentage dosage adjustments are calculated using the intermittent dose rather than the total daily dose (eg if standard dosing for drug X is 500 mg 6-hourly, then 50% at normal dosing interval = 250 mg 6-hourly, and 100% 12-hourly = 500 mg 12-hourly). | |
